Amyris Inc: (NASD: AMRS)

$2.66

-0.04 (-1.48%)

Volume 82,470

Jun 19 04:00 PM ET

Zacks Rank: 3-Hold

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		2.65 - 2.77
	
		52wk Low - High
		2.16 - 4.56
	
		Previous Close
		2.70
	
		Avg. Volume
		182,214
	
		Industry
		BIOFUELS
	
		Market Cap
		204.55 M
	
		Div - Yield
		0.00 - 0.00
	
		Beta
		0.15
	
		P/E (F1)
		0.00
	
		Current Year Est.
		-1.63
	
		Quarterly Earnings ESP 
		NA
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		3
Hold

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		215 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 06/14/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            P/E (F1)
                            NA
                        
                            PEG Ratio
                            NA
                        
                            Current Year Est.
                            -1.63
                        
                            Current Quarter Estimate
                            -0.45
                        
                            Most Accurate Estimate
                            NA
                        
                            Earnings ESP 
                            NA
                        
                            Next Earnings Report Date
                            08-06-2013
                        
                            EPS Last Year
                            -2.16
                        
                            Expected Earnings Growth
                            30.00%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Amyris INC is an integrated renewable products company applying industrial synthetic biology to genetically modify microorganisms to serve as living factories. Amyris designs these microorganisms to produce defined molecules for use as renewable chemicals and transportation fuels. The Company is engaged in the development of farmesene- a molecule, which serves as the base chemical building block for a wide range of renewable products to replace existing products that are derived from petroleum, plant or animal sources and that may be of lower quality or higher price. Amyris INC is headquartered in Emeryville, CA.   
Full AMRS Company Report

 Snapshot on AMRS

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
AMRS Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	-0.45	-0.38	-1.63	-1.02
Number of Estimates	4	4	4	4
Low Estimate	-0.54	-0.45	-1.90	-1.31
High Estimate	-0.36	-0.27	-1.31	NA
Year Ago EPS	-0.81	-0.32	-2.80	-1.63
EPS Growth	44.75%	-18.75%	41.87%	37.02%

More AMRS Estimates

Average Earnings Estimates for AMRS

EPS Growth for AMRS

Industry Analysis

Name	Symbol	Previous Close
AMYRIS INC	AMRS	2.70
RENEWABLE ENERG	REGI	12.97
FUTUREFUEL CORP	FF	14.70
SOLAZYME INC	SZYM	12.04
GREEN PLN RENEW	GPRE	14.47
KIOR INC-A	KIOR	4.23
GREENHUNTER EGY	GRH	1.12
VERENIUM CORP	VRNM	2.29
RENTECH INC	RTK	2.15
REX AMERICAN RS	REX	33.92

Sector:Oils-Energy>> Industry:BIOFUELS

COMPARE TICKER vs. Its Peers

Zacks Commentary

Zacks Rank #1 Addition for Thursday

Feb 14, 2013

AGL Resources Buys NiSource Assets

Feb 04, 2013

Zacks #1 Rank Additions for Monday

Feb 04, 2013

Zacks Rank #1 Addition for Thursday

Jan 31, 2013

Zacks Rank #1 Addition for Monday

Jan 28, 2013

Zacks #1 Rank Additions for Tuesday

Jan 15, 2013

Zacks #1 Rank Additions for Friday

Jan 11, 2013

Zacks #1 Rank Additions for Tuesday

Jan 08, 2013

More AMRS Zacks Commentary

Financials

EPS TTM	-2.16
Sales	74
Net Income	-143
Price/Earnings	NA
Price/Book	3.39
Price/Cash Flow	NA
Price/Sales	3.93

More AMRS Financials

News

Investor Alert: Holzer Holzer & Fistel, LLC Advises Investors of Upcoming Deadlines in Shareholder Litigation Involving Delcath Systems, Inc., Amyris, Inc., Nam Tai Electronics, Inc. and Accretive Health, Inc. - Businesswire

Jun 18, 2013

Western Refining is Among the Companies in the Oil & Gas Refining & Marketing Industry With the Highest Beta (WNR, AMRS, VLO) - Financial News Network Online - News Corner

Jun 13, 2013

3 Opportunities for Solazyme Investors - TheMotleyFool

Jun 12, 2013

Is BioAmber a Good Long-Term Investment? - TheMotleyFool

May 30, 2013

Has This New Biotech Industry Learned Its Lesson? - TheMotleyFool

May 29, 2013

The Ultimate Biotech Diversification Strategy - TheMotleyFool

May 26, 2013

Law Offices of Todd M. Garber Announces Investigation of Amyris, Inc. - Businesswire

May 24, 2013

Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Amyris, Inc. - Pr Newswire

May 23, 2013

See All News Stories on AMRS

Broker Recommendations

Current ABR	3.00
ABR (Last Week)	3.00
# of recs in ABR	6
Average Target Price	3.50
Industry Rank by ABR	215 out of 265
Rank in Industry	3 out of 10

More AMRS Broker Recommendations

Day Low - High	2.65 - 2.77
52wk Low - High	2.16 - 4.56
Previous Close	2.70
Avg. Volume	182,214
Industry	BIOFUELS
Market Cap	204.55 M
Div - Yield	0.00 - 0.00
Beta	0.15
P/E (F1)	0.00
Current Year Est.	-1.63
Quarterly Earnings ESP	NA

P/E (F1)	NA
PEG Ratio	NA
Current Year Est.	-1.63
Current Quarter Estimate	-0.45
Most Accurate Estimate	NA
Earnings ESP	NA
Next Earnings Report Date	08-06-2013
EPS Last Year	-2.16
Expected Earnings Growth	30.00%

Username: Password:

Remember me [?]

Amyris Inc: (NASD: AMRS)

$2.66

-0.04 (-1.48%)

Volume 82,470

Jun 19 04:00 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description